The BAFFling Immunology of Systemic Lupus Erythematosus: Beyond B Cells

被引:3
作者
Stohl, William [1 ]
机构
[1] Univ So Calif, Los Angeles, CA 90033 USA
关键词
NECROSIS-FACTOR FAMILY; LYMPHOCYTE STIMULATOR; ACTIVATING FACTOR; MATURATION ANTIGEN; T-CELL; AUTOIMMUNE-DISEASE; 2328; MICE; RECEPTOR; TACI; SURVIVAL;
D O I
10.1002/art.38951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:612 / 615
页数:4
相关论文
共 39 条
[21]   Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial [J].
Navarra, Sandra V. ;
Guzman, Renato M. ;
Gallacher, Alberto E. ;
Hall, Stephen ;
Levy, Roger A. ;
Jimenez, Renato E. ;
Li, Edmund K-M ;
Thomas, Mathew ;
Kim, Ho-Youn ;
Leon, Manuel G. ;
Tanasescu, Coman ;
Nasonov, Eugeny ;
Lan, Joung-Liang ;
Pineda, Lilia ;
Zhong, Z. John ;
Freimuth, William ;
Petri, Michelle A. .
LANCET, 2011, 377 (9767) :721-731
[22]   B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells [J].
Ng, LG ;
Sutherland, APR ;
Newton, R ;
Qian, F ;
Cachero, TG ;
Scott, ML ;
Thompson, JS ;
Wheway, J ;
Chtanova, T ;
Groom, J ;
Sutton, IJ ;
Xin, C ;
Tangye, SG ;
Kalled, SL ;
Mackay, F ;
Mackay, CR .
JOURNAL OF IMMUNOLOGY, 2004, 173 (02) :807-817
[23]  
Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO
[24]  
2-5
[25]   Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study [J].
Rovin, Brad H. ;
Furie, Richard ;
Latinis, Kevin ;
Looney, R. John ;
Fervenza, Fernando C. ;
Sanchez-Guerrero, Jorge ;
Maciuca, Romeo ;
Zhang, David ;
Garg, Jay P. ;
Brunetta, Paul ;
Appel, Gerald .
ARTHRITIS AND RHEUMATISM, 2012, 64 (04) :1215-1226
[26]   TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology [J].
Sasaki, Y ;
Casola, S ;
Kutok, JL ;
Rajewsky, K ;
Schmidt-Supprian, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (04) :2245-2252
[27]   An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway [J].
Schiemann, B ;
Gommerman, JL ;
Vora, K ;
Cachero, TG ;
Shulga-Morskaya, S ;
Dobles, M ;
Frew, E ;
Scott, ML .
SCIENCE, 2001, 293 (5537) :2111-2114
[28]   BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth [J].
Schneider, P ;
MacKay, F ;
Steiner, V ;
Hofmann, K ;
Bodmer, JL ;
Holler, N ;
Ambrose, C ;
Lawton, P ;
Bixler, S ;
Acha-Orbea, H ;
Valmori, D ;
Romero, P ;
Werner-Favre, C ;
Zubler, RH ;
Browning, JL ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1747-1756
[29]   Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen [J].
Schneider, P ;
Takatsuka, H ;
Wilson, A ;
Mackay, F ;
Tardivel, A ;
Lens, S ;
Cachero, TG ;
Finke, D ;
Beermann, F ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (11) :1691-1697
[30]   B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation [J].
Shulga-Morskaya, S ;
Dobles, M ;
Walsh, ME ;
Ng, LG ;
MacKay, F ;
Rao, SP ;
Kalled, SL ;
Scott, ML .
JOURNAL OF IMMUNOLOGY, 2004, 173 (04) :2331-2341